First report on two cases of pleomorphic dermal sarcoma successfully treated with immune checkpoint inhibitors

First report on two cases of pleomorphic dermal sarcoma successfully treated with immune checkpoint inhibitors

Pleomorphic dermal sarcoma (PDS) is one of the most common sarcoma of the skin. Currently, limited treatment options exist for advanced stages of the disease. While immune checkpoint inhibitors (CPIs) have revolutionized cancer treatment options–their efficacy in PDS has not been explored yet. Here,...

Full description

Bibliographic Details
Main Authors: Sebastian Klein, Oana-Diana Persa, Cornelia Mauch, Ka-Won Noh, Roberto Pappesch, Svenja Wagener-Ryczek, Reinhard Buettner, Alexander Quaas, Doris Helbig
Format: Article
Language:English
Published: Taylor & Francis Group 2019-12-01
Series:OncoImmunology
Subjects:
pleomorphic dermal sarcoma (pds)
sarcoma of the skin
pd-1 inhibition
immunotherapy
pembrolizumab
Online Access:http://dx.doi.org/10.1080/2162402X.2019.1665977

Internet

http://dx.doi.org/10.1080/2162402X.2019.1665977

Similar Items